|
|
Vol. 15.13 – 17 May, 2024
|
|
|
|
|
|
|
|
Investigations of glutamine (Gln) deprivation on docetaxel-sensitive and -resistant (DR) prostate cancer cells revealed that the DR cell sub-lines were susceptible to Gln deprivation. [Oncogene]
|
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
|
|
|
Based on bioinformatics analysis, investigators evaluated the relationship between cyclin-dependent kinase 12 deficiency and prostate cancer patient’s prognosis and treatment resistance.
[Clinical and Translational Medicine]
|
|
|
|
|
|
PC3 cells were transfected with siLLGL2 or plasmid LLGL2 and autophagy was examined. Invasion, migration, and wound healing were assessed in PC3 cells under autophagy regulation.
[Biological Research]
|
|
|
|
|
|
The authors investigated the role of the Wnt signaling modulator Dickkopf-1 (DKK1) in the growth and metastatic progression of metastatic CRPC.
[Cancer Gene Therapy]
|
|
|
|
|
|
Investigators explored how electrons in the very high energy electrons (VHEE) range could be used to perform successful in vitro radiobiological studies.
[Scientific Reports]
|
|
|
|
|
|
Scientists hypothesized that neuroendocrine differentiated cells secreted neuropeptides that supported androgen-independent tumor growth and induced aggressiveness of adjacent proliferating tumor cells through a paracrine mechanism. [PLOS One]
|
|
|
|
|
|
|
|
The authors collected a large amount of evidence on the anti-prostate cancer effects of these six flavonoids, including a large number of cellular experiments and a small number of preclinical animal experiments. [Molecular Biology Reports]
|
|
|
|
|
|
|
|
A team led by Dr. Eddie Imada has been awarded a three-year, $1.5 million United States Department of Defense grant for research on a cellular process called alternative polyadenylation and its role in prostate cancer. [Weill Cornell Medicine (EurekAlert)]
|
|
|
|
|
|
|
|
May 29 – June 1, 2024 Vancouver, British Columbia, Canada
|
|
|
|
|
|
|
|
|
|
|
University of Alabama at Birmingham – Birmingham, Alabama, United States
|
|
|
|
|
|
|
Dana Farber Cancer Institute – Boston, Massachusetts, United States
|
|
|
|
|
|
|
Radboud University Medical Center – Nijmegen, Netherlands
|
|
|
|
|
|
|
Fondazione per l’Istituto oncologico di ricerca – Bellinzona, Switzerland
|
|
|
|
|
|
|
University of Pittsburgh – Pittsburgh, Pennsylvania, United States
|
|
|
|
|
|